During the last session, Fractyl Health Inc (NASDAQ:GUTS)’s traded shares were 0.31 million, with the beta value of the company hitting 0.01. At the end of the trading day, the stock’s price was $1.22, reflecting an intraday gain of 9.91% or $0.11. The 52-week high for the GUTS share is $7.89, that puts it down -546.72 from that peak though still a striking 28.69% gain since the share price plummeted to a 52-week low of $0.87. The company’s market capitalization is $59.68M, and the average intraday trading volume over the past 10 days was 0.35 million shares, and the average trade volume was 280.03K shares over the past three months.
Fractyl Health Inc (GUTS) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. GUTS has a Sell rating from 0 analyst(s) out of 1 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 1 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.5.
Fractyl Health Inc (NASDAQ:GUTS) trade information
Fractyl Health Inc (GUTS) registered a 9.91% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 9.91% in intraday trading to $1.22, hitting a weekly high. The stock’s 5-day price performance is 28.79%, and it has moved by -3.17% in 30 days. Based on these gigs, the overall price performance for the year is -82.14%. The short interest in Fractyl Health Inc (NASDAQ:GUTS) is 2.93 million shares and it means that shorts have 14.68 day(s) to cover.
Fractyl Health Inc (GUTS) estimates and forecasts
In the rating firms’ projections, revenue will decrease -100.00% compared to the previous financial year.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -12.32%. While earnings are projected to return 10.08% in 2025, the next five years will return 12.51% per annum.
GUTS Dividends
Fractyl Health Inc is due to release its next quarterly earnings on 2025-Mar-02. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Fractyl Health Inc (NASDAQ:GUTS)’s Major holders
Fractyl Health Inc insiders own 4.71% of total outstanding shares while institutional holders control 83.34%, with the float percentage being 87.46%. DEER MANAGEMENT CO. LLC is the largest shareholder of the company, while 89.0 institutions own stock in it. As of 2024-06-30, the company held over 4.77 million shares (or 9.9603% of all shares), a total value of $20.37 million in shares.
The next largest institutional holding, with 4.67 million shares, is of HCC MANAGER LLC’s that is approximately 9.7577% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $34.59 million.
Also, the Mutual Funds coming in first place with the largest holdings of Fractyl Health Inc (GUTS) shares are VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF . Data provided on Dec 31, 2024 indicates that VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund owns about 981.76 shares. This amounts to just over 2.01 percent of the company’s overall shares, with a $1.2 million market value. The same data shows that the other fund manager holds slightly less at 897.81, or about 1.84% of the stock, which is worth about $1.1 million.
